Big-name tech investors pour millions into marijuana — both medicinal and not

As California gears up to legalize recreational marijuana, wealthy investors are rushing to back new products, both for health and for pleasure.

OAKLAND, Calif. — The storied Silicon Valley venture firm Benchmark Capital has launched a slew of tech companies: Twitter, Uber, Snapchat, Instagram. Now its search for the next big thing has led it to … pot.

Benchmark recently invested $8 million in Hound Labs, a startup here in Oakland that’s developing a device for drivers — and law enforcement — to test whether they’re too buzzed to take the wheel.

And that’s just the start. Wealthy investors are pouring tens of millions into the cannabis industry in a bid to capitalize on the gold rush that’s expected when California legalizes, including DNA analysis of each strain, to help customers find the perfect match.

Sie lesen eine Vorschau. Registrieren Sie sich, um mehr zu lesen.

Mehr von STAT

STAT1 min gelesenScience
STAT Plus: Pharmalittle: BioNTech Expects To Seek Approval For Vaccine By Year-end; Why The FDA Chose A 50% Threshold For Covid-19 Vaccines
Peter Marks, a top FDA official, shed light on the reasoning behind the agency's choice of a 50% efficacy threshold for a Covid-19 vaccine.
STAT1 min gelesen
STAT Plus: Pharmalittle: NIH To Test Blood Thinners Against Covid-19; AbbVie Employees Feel Pressured To Return To Work
U.S. researchers have begun two clinical trials examining the use of blood thinners to help Covid-19 patients avoid clotting that has led to strokes, heart attacks, and organ failure.
STAT1 min gelesen
STAT Plus: Pharmalittle: Drug Makers Build Covid-19 Vaccine Supply Chains; VCs Are Still Spending On Biotechs
Drug makers racing to develop Covid-19 vaccines are already working behind the scenes to build the supply chains needed to deliver their drugs to billions of people as rapidly as…